Literature DB >> 8678714

Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.

F Barbut1, G Corthier, Y Charpak, M Cerf, H Monteil, T Fosse, A Trévoux, B De Barbeyrac, Y Boussougant, S Tigaud, F Tytgat, A Sédallian, S Duborgel, A Collignon, M E Le Guern, P Bernasconi, J C Petit.   

Abstract

BACKGROUND: Although Clostridium difficile is the main agent responsible for nosocomial diarrhea in adults, its prevalence in stool cultures sent to hospital microbiology laboratories is not clearly established.
OBJECTIVES: To determine the prevalence of C difficile in inpatient stools sent to hospital microbiology laboratories and to assess the relationship between serotypes and toxigenicity of the strains isolated and the clinical data.
METHODS: From January 18, 1993, to July 31, 1993, the presence of C difficile was systematically investigated in a case-control study on 3921 stool samples sent for stool culture to 11 French hospital microbiology laboratories. The prevalence of C difficile in this population (cases) was compared with that of a group of 229 random hospital controls matched for age, department, and length of stay (controls). Stool culture from controls was requested by the laboratory although not prescribed by the clinical staff. Serotype and toxigenesis of the strains isolated were compared.
RESULTS: The overall prevalence of C difficile in the cases was twice the prevalence in the controls (9.7% vs 4.8%; P < .001) and was approximately 4 times as high in diarrheal stools (ie, soft or liquid) as in normally formed stools from controls (11.5% vs 3.3%; P < .001). The strains isolated from diarrheal stools were more frequently toxigenic than those isolated from normally formed stools. Serogroup D was never toxigenic, and its proportion was statistically greater in the controls than in the cases (45% vs 18%; chi 2 = 5.2; P < .05). Conversely, serogroup C was isolated only from the cases. Clostridium difficile was mainly found in older patients ( > 65 years), suffering from a severe disabling disease, who had been treated with antibiotics and hospitalized for more than 1 week in long-stay wards or in intensive care.
CONCLUSIONS: This multicenter period prevalence study clearly supports the hypothesis of a common role of C difficile in infectious diarrhea in hospitalized patients. Disease associated with C difficile should therefore be systematically evaluated in diarrheal stools from inpatients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8678714

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  36 in total

1.  In vitro activity of linezolid against Clostridium difficile.

Authors:  T Peláez; R Alonso; C Pérez; L Alcalá; O Cuevas; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

Authors:  F Barbut; A Richard; K Hamadi; V Chomette; B Burghoffer; J C Petit
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.

Authors:  Anne-Marie Bourgault; François Lamothe; Vivian G Loo; Louise Poirier
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

Review 4.  Refractory Clostridium difficile-associated diarrhea.

Authors:  Shilpa Grover; Matthew J Hamilton; David L Carr-Locke
Journal:  MedGenMed       Date:  2007-05-29

5.  Clostridium difficile-associated diarrhea - the new scourge of the health care facility.

Authors:  J Conly
Journal:  Can J Infect Dis       Date:  2000-01

6.  Clostridium difficile colitis acquired in the intensive care unit: outcome and prognostic factors.

Authors:  L Sabau; A Meybeck; J Gois; P Devos; P Patoz; N Boussekey; P-Y Delannoy; A Chiche; H Georges; O Leroy
Journal:  Infection       Date:  2013-06-19       Impact factor: 3.553

7.  Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.

Authors:  David M Faleck; Hojjat Salmasian; E Yoko Furuya; Elaine L Larson; Julian A Abrams; Daniel E Freedberg
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

8.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

9.  N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project.

Authors:  M Hyland; M Ofner-Agostini; M Miller; S Paton; M Gourdeau; M Ishak
Journal:  Can J Infect Dis       Date:  2001-03

10.  Clostridium difficile as a cause of acute diarrhea: a prospective study in a tertiary care center.

Authors:  Meghraj Ingle; Abhijit Deshmukh; Devendra Desai; Philip Abraham; Anand Joshi; Tarun Gupta; Camilla Rodrigues
Journal:  Indian J Gastroenterol       Date:  2013-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.